Know more... - Pancreatic Cancer India

Dr Bhawna Sirohi’s CV
49. Arkenau HT, Chong G, Cunningham D, Watkins D, Sirohi B, Chau I,
Wotherspoon A, Norman A, Horwich A, Matutes E Gemcitabine, cisplatin and
methylprednisolone for the treatment of patients with peripheral T-cell lymphoma:
the Royal Marsden Hospital experience. Haematologica. 2007 Feb;92(2):271-2.
50. Sirohi B, Powles, R, Oakervee H., Singhal S., Bishop L., Horton C., Kulkarni
S., Barnett M., Dyer P., Rintala T., Mehta J, Cavenagh J.D. Upfront Collection of
Peripheral Blood Stem Cells (PBSC) in New Patients with Myeloma Receiving
Minimal or No Prior Cytoreductive Therapy: Comparison of Two Regimes from
Royal Marsden Hospital and St. Bartholomew's Hospital. – Haematology 2007
Apr;12(2):113-5.
51. Sirohi B, Powles R, Lawrence D., Kulkarni S., Hollis H., Heming D., Sankpal
S., Patel G., Singhal S., Treleaven J. Mehta J. An Open, Randomized,
Controlled, Phase II, Single Centre, Two-Period Cross Over Study To Compare
the Quality of Life (QoL) and Toxicity Experienced on PEG Interferon (P-IFN)
with Interferon-a2b (IFN) in Patients with Multiple Myeloma (MM) Maintained
on a Steady Dose of IFN- Annals of Oncology 2007 Aug;18(8):1388-94.
52. Sirohi, B Cunningham D, Norman A, Last K, Chau I, Horwich A, Oates J,
Chong G, Wotherspoon A. Gemcitabine, cisplatin and methylprednisolone (GEM-
P) with or without Rituximab in relapsed and refractory patients with diffuse large
B cell lymphoma (DLBCL).Hematology. 2007 Apr;12(2):149-53.
53. Murphy F, Sirohi B, Cunningham D. Autotransplantation in Hodgkin
Lymphoma. Expert Rev Cancer Therapy. 2007 Mar;7(3):297-306.
54. Formica V, Wotherspoon A, Cunningham D, Norman AR, Sirohi B, Oates J,
Chong G. The prognostic role of WHO classification, urinary 5-
hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine
carcinomas of the gastroenteropancreatic tract. Br J Cancer. 2007 Apr
23;96(8):1178-82
55. Sirohi B, Ashley S, Norton A, Popat S, Hughes S, Papadopoulos P, Priest
K,O’Brien M Early response to platinum-based first line chemotherapy in non
small cell lung cancer (NSCLC) may predict survival. Journal of Thoracic
Oncology 2007 Aug;2(8):735-40.
56. Sirohi, B, Powles R, Harousseau JL, Anderson KC. The evolving background for
high-dose treatment for myeloma. Bone Marrow Transplant 2007;
Dec;40(12):1097-100.
57. Sirohi, B, Powles R. Future Challenges. Bone Marrow Transplant 2007;
Dec;40(12):1057-64.
58. Sirohi B, Cunningham D, Powles R, Murphy F, Arkenau T, Norman A, Oates J,
Wotherspoon A, Horwich A. Long-term outcome of autologous stem cell
transplantation in relapsed or refractory Hodgkin Lymphoma. Ann Oncol 2008
Jul; 19(7):1312-9. Epub 2008 Mar 19
59. Sirohi B, Powles R, Treleaven J, Kulkarni S, Saso R, Potter M, Ethell M, Morgan
G, Singhal S, Mehta J. The role of maintenance chemotherapy after
autotransplantation for acute lymphoblastic leukemia in first remission: singlecenter
experience of 100 patients. Bone Marrow Transplant. 2008 Jul;42(2):105-
12. Epub 2008 Apr 14.
60. Fliedner TM, Powles R, Sirohi B, Niederwieser D; European Group for Blood
and Marrow Transplantation (EBMT) Nuclear Accident Committee (NAC).
Radiologic and nuclear events: the METREPOL severity of effect grading system.
Blood. 2008 Jun 15;111(12):5757-8; author reply 5758-9.
30